2022 Cannabis Industry Outlook: Your Business’ Future Depends on its Risk Management
Cannabis risks have always outpaced the availability of insurance, in large part because of its status as a federally illegal substance and […]
Cannabis risks have always outpaced the availability of insurance, in large part because of its status as a federally illegal substance and […]
A small study of children with treatment-resistant epilepsy has found that whole-plant cannabis therapies reduced seizures by 86 percent, according to research […]
2021 Cannabis Labs Virtual Conference: December Program Sponsored by ANAB, Hardy Diagnostics and MilliporeSigma. Click here to watch the recording Agenda Cannabis Laboratory […]
On December 2, ASTM International, released a whitepaper called “Delta-8-Tetrahydrocannabinol and the Need to Develop Standards to Protect Safety of Consumers.” On the […]
A bipartisan group of lawmakers wants to establish federal standards for the CBD market that has blossomed in recent years. U.S. House […]
Natural cannabinoid distillates and isolates are hydrophobic oils and solids, meaning that they do not mix well with water and are poorly […]
CNN announced on November 22 that it would be airing the sixth installment of its cannabis series, WEED 6: Cannabis and Autism, […]
The cannabinoid industry has faced an uphill battle from the beginning due to a lack of reliable scientific awareness about cannabinoids, fueled […]
Three years ago, Canada became one of the first countries in the world to legalize and regulate cannabis. We’ve covered various aspects […]
The supply chain for consumer cannabis products is complex, involving cultivation, extraction, manufacturing and packaging. While global best practices exist for Good […]